Doctor’s Choice Home Care, Inc. and its former owners, Timothy Beach and Stuart Christensen, have agreed to pay $5.15 million to resolve allegations that the home health agency provided improper financial inducements to referring physicians through sham medical director agreements and bonuses to physicians’ spouses who were Doctor’s Choice employees, the Department of Justice announced today.
Timothy Beach and Stuart Christensen founded Doctor’s Choice and formerly served as its top executives. Doctor’s Choice is a home health agency based in Sarasota, Florida, with branches throughout the state.
Doctor’s Choice will pay $3,856,000 to settle these allegations and Beach and Christensen will each pay $647,000. Doctor’s Choice will pay an additional $675,000 to resolve separate allegations that employees pressured clinical personnel to increase the number of home visits for Medicare patients to avoid the Medicare Low Utilization Payment Adjustment that would have decreased the reimbursement Doctor’s Choice received from Medicare in the absence of these unnecessary services.
“The Department of Justice will continue to hold companies and individuals accountable for the payment of illegal remuneration in any form,” said Acting Assistant Attorney General Jeffrey Bossert Clark of the Department of Justice’s Civil Division. “Improper inducements have no place in our federal healthcare system, which relies on healthcare providers making decisions based on the healthcare needs of their patients and rather than their personal financial interests.”
“Operating an illegal referral scheme and providing medically unnecessary services places patients at risk and jeopardizes millions of taxpayer dollars,” said Special Agent in Charge of the FBI Tampa Division Michael McPherson. “This settlement highlights the FBI’s commitment to protect the integrity of the federally funded healthcare system.”
The Anti-Kickback Statute prohibits the offering or payment of remuneration to induce or reward referrals for services paid for by federal healthcare programs. The Stark Law forbids certain medical providers, including home health agencies, from submitting claims to Medicare for services provided to patients who were referred by a physician with whom the provider has a prohibited financial relationship, unless that relationship falls within an applicable exception.
This settlement resolves allegations that Doctor’s Choice, Beach, and Christensen violated the Anti-Kickback Statute and the Stark Law by entering into sham medical director agreements with physicians as a means of providing remuneration for referrals, and also violated the Stark Law by providing bonuses to employees based on referrals to Doctor’s Choice by the employees’ physician spouses. In addition, the agreement resolves allegations that Doctor’s Choice provided unnecessary services to Medicare patients in order to increase the number of skilled services provided during a home health visit to avoid the Low Utilization Payment Adjustment which otherwise would have decreased Doctor’s Choice Medicare reimbursement. This adjustment is triggered when a home health patient has a treatment episode consisting of less than five skilled service visits and results in the provider receiving a standardized per visit payment rather than the higher payment for a full home health episode.
The allegations resolved in this settlement were originally brought in two lawsuits filed under the qui tam, or whistleblower, provisions of the False Claims Act; one case was filed by Corina Herbold and the second case was filed by Sara Billings, Misty Sykes, and Marina Eschoyez-Quiroga, all of whom are former employees of Doctor’s Choice. The Act permits private parties to sue on behalf of the government for false claims for government funds and to receive a share of any recovery. Billings, Sykes, and Eschoyez-Quiroga will jointly receive a share of approximately $145,000 arising from the government’s recovery for the Low Utilization Payment Adjustment allegations. Herbold’s share has not yet been determined.
The government’s intervention in these matters illustrates its emphasis on combating health care fraud. One of the most powerful tools in this effort is the False Claims Act. Tips and complaints from all sources about potential fraud, waste, abuse, and mismanagement, can be reported to the Department of Health and Human Services, at 800-HHS-TIPS (800-447-8477).
The settlement was the result of a coordinated effort by the Civil Division of the Department of Justice, the U.S. Attorney’s Office for the Middle District of Florida, the Office of Inspector General of the Department of Health and Human Services, and the FBI.
The cases are captioned United States ex rel. Herbold v. Doctor’s Choice Home Care Inc., et al., No. 8:15- cv-01044 (M.D. Fla.) and United States ex rel. Billings, Sykes, and Eschoyez-Quiroga v. Doctor’s Choice Home Care Inc., No. 8:16-cv-3112 (M.D. Fla.).
The claims resolved by the settlement are allegations only; there has been no determination of liability.
Greetings I’m Sam.
I edit, report and maintain this site. If you have any questions You can mail below me but it could be a while before I get back to you.
- Secretary Michael R. Pompeo and Israeli Prime Minister Benjamin NetanyahuBy Sam NewsNovember 19, 2020
- Justice Department Requires Divestiture In Order For Liberty Latin America To Acquire AT&T’s Telecommunications Operations In Puerto Rico And The U.S. Virgin IslandsBy Sam NewsOctober 23, 2020The Department of Justice announced today that it is requiring Liberty Latin America Ltd. (Liberty), its subsidiary, Liberty Communications of Puerto Rico LLC (LCPR), and AT&T Inc. (AT&T) to divest certain fiber-based telecommunications assets and customer accounts in Puerto Rico, in order for Liberty to proceed with its proposed acquisition of AT&T’s wireline and wireless telecommunications operations in Puerto Rico and the U.S. Virgin Islands. The department has approved WorldNet Telecommunications, Inc. (WorldNet) as the acquirer.[Read More…]
- Justice Department Reaches Major Olmstead Settlement Agreement with North DakotaBy Sam NewsDecember 14, 2020The Justice Department today announced a settlement agreement with the State of North Dakota under the Americans with Disabilities Act (ADA). The agreement resolves complaints alleging that North Dakota unnecessarily institutionalizes individuals with disabilities in nursing facilities, instead of providing them the services they need to live in the community.[Read More…]
- Facial Recognition Technology: Privacy and Accuracy Issues Related to Commercial UsesBy Sam NewsAugust 11, 2020Market research and other data suggest that the market for facial recognition technology has increased in the number and types of businesses that use it since GAO's 2015 report on the topic (GAO-15-621 ). For example, newer functions of the technology identified by stakeholders and literature included authorizing payments and tracking and monitoring attendance of students, employees, or those attending events. Functions of Facial Recognition Technology Accuracy. Although the accuracy of facial recognition technology has increased dramatically in recent years, differences in performance exist for certain demographic groups. National Institute of Standards and Technology tests found that facial recognition technology generally performs better on lighter-skin men and worse on darker-skin women, and does not perform as well on children and elderly adults. These differences could result in more frequent misidentification for certain demographics, such as misidentifying a shopper as a shoplifter when comparing the individual's image against a data set of known shoplifters. There is no consensus on what causes performance differences, including physical factors (such as lighting) or factors related to the creation or operation of the technology. However, stakeholders and literature identified various methods that could help mitigate differences in performance among demographic groups. Privacy. Stakeholders and literature identified concerns related to privacy, such as the inability of individuals to remain anonymous in public or the use of the technology without individuals' consent. Facial recognition technology may collect or store facial images, posing varying levels of risk. Some federal and state laws and the European Union's General Data Protection Regulation impose requirements on U.S. companies related to facial recognition technology. However, as we reported in 2015, there is no comprehensive federal privacy law governing the collection, use, and sale of personal information by private-sector companies. Some stakeholders, including privacy and industry groups, have developed voluntary frameworks that seek to address privacy concerns. Most of these frameworks were consistent with internationally recognized principles for protecting the privacy and security of personal information. However, U.S. companies are not required to follow these voluntary frameworks. Facial recognition technology can verify or identify an individual from a facial image. Advocacy groups and others have raised privacy concerns related to private companies' use of the technology, as well as concerns that higher error rates among some demographic groups could lead to disparate treatment. GAO was asked to review the commercial use of facial recognition technology and related accuracy and privacy issues. Among other issues, this report examines how companies use the technology, its accuracy and how accuracy differs across demographic groups, and how privacy issues are addressed in laws and industry practices. GAO analyzed laws; reviewed literature and company documentation; interviewed federal agency officials; and interviewed representatives from companies, industry groups, and privacy groups. GAO also reviewed selected privacy frameworks, chosen based on expert recommendations and research. GAO reiterates its previous suggestion from a 2013 report ( GAO-13-663 ) that Congress consider strengthening the consumer privacy framework to reflect changes in technology and the marketplace. For more information, contact Alicia Puente Cackley at (202) 512-8678 or email@example.com.[Read More…]
- Pineville Man Charged with Forced Labor and Transporting a Minor with Intent to Engage in Criminal Sexual ActivityBy Sam NewsJuly 31, 2020Darnell Fulton, 36, was charged today in a multiple count indictment with charges including forced labor, conspiracy, and transportation of a minor with the intent to engage in criminal sexual activity, announced Eric S. Dreiband, Assistant Attorney General for Civil Rights, and David C. Joseph, U.S. Attorney for the Western District of Louisiana.[Read More…]
- Over-The-Counter Drugs: Information on FDA’s Regulation of Most OTC DrugsBy Sam NewsJuly 30, 2020The Food and Drug Administration (FDA) has regulated most over-the-counter (OTC) drugs—that is, drugs available without a prescription—through the OTC monograph process. FDA has described an OTC monograph as a "rulebook" for marketing safe and effective OTC drugs, such as aspirin, cough and cold medicine, and hand sanitizer. OTC monographs established conditions—such as active ingredients, indications for use, dosage forms, and product labeling—under which an OTC drug was generally recognized as safe and effective. According to FDA officials, before the CARES Act, which was enacted in March 2020, the agency's ability to update and finalize monographs in response to safety issues and to reflect new scientific information was limited by the rulemaking process the agency was required to follow, as well as insufficient resources. Agency officials estimated that it took at least 6 years to complete the required rulemaking process. Additionally, the agency reported it was critically under-resourced to regulate the estimated 100,000 OTC drugs marketed through the monograph process. However, the CARES Act provided for a new process to regulate these OTC drugs rather than the rulemaking process. FDA officials expect it will take less time to update and finalize requirements for OTC drugs using the new process. The CARES Act also authorized FDA to assess user fees to provide additional resources to regulate OTC drugs. Although FDA officials said this new process and user fees should improve its regulation of OTC drugs, the agency's analysis of the effect of the CARES Act is still ongoing. FDA officials told GAO that prior to the CARES Act, they used various methods to identify and respond to safety issues related to OTC drugs. For example, to identify these issues, FDA officials said they read medical literature related to safety issues and reviewed reports submitted to the agency's adverse event reporting system. To respond to these issues, FDA took steps such as issuing drug safety communications to consumers and requesting that manufacturers make changes to a drug's labeling. For example, in 2015, two FDA advisory committees recommended that cough and cold drugs with codeine be removed from the relevant OTC monograph for use in drugs in children. In 2018, FDA also issued a drug safety communication stating the risks outweighed the benefits for the use of these drugs in children. However, FDA officials said these methods were not a substitute for rulemaking because manufacturers could legally market their OTC drugs without making requested safety changes until the rulemaking process was completed. According to FDA officials, the new process for regulating OTC drugs included in the CARES Act could improve FDA's ability to address identified safety risks in a more timely and efficient manner in the future. The act established an expedited process to address safety issues that pose an imminent hazard to public health or to change a drug's labeling to mitigate a significant or unreasonable risk of a serious adverse event. OTC drugs prevent and treat a variety of conditions; for example, sunscreen is used to help prevent sunburn. FDA officials and stakeholders, such as industry representatives and patient and provider groups, have questioned whether the monograph process used to regulate most OTC drugs has been overly burdensome and has limited FDA's ability to quickly update and finalize monographs in response to potential safety issues for consumers. Enacted in March 2020, the CARES Act changed how FDA regulates OTC drugs. The Sunscreen Innovation Act included a provision for GAO to review FDA's regulation of OTC drugs. This report describes, among other issues, (1) the factors that affected FDA's ability to regulate OTC drugs and (2) how FDA identified and responded to safety issues associated with these drugs. GAO reviewed federal statutes and agency documents and interviewed FDA officials and stakeholders familiar with the monograph process. These stakeholders included representatives from the OTC drug industry, health care provider and consumer groups, and researchers. The Department of Health and Human Services provided technical comments on this report, which GAO incorporated as appropriate. For more information, contact John E. Dicken at (202) 512-7114 or firstname.lastname@example.org.[Read More…]
- Burkina Faso’s National DayBy Sam NewsDecember 11, 2020
- U.S. Department of State to Honor Foreign Service Officer (ret.) William S. Rowland as Hero of U.S. DiplomacyBy Sam NewsSeptember 28, 2020
- Disabilities Reported by Prisoners: Survey of Prison Inmates, 2016By Sam NewsIn Justice NewsMay 2, 2021(Publication)
This brief presents findings based on data collected in the 2016 Survey of Prison Inmates, a survey conducted through face-to-face interviews with a national sample of state and federal prisoners across a variety of topics, such as their demographic characteristics, socio-economic background, health, and involvement with the criminal justice system.
3/30/2021, NCJ 252642, Mariel Alper, Jennifer Bronson, Laura M. Maruschak [Read More…]
- Framework Agreement for Israel-Lebanon Maritime DiscussionsBy Sam NewsOctober 1, 2020
- Department of Justice Announces the Use of Body-Worn Cameras on Federal Task ForcesBy Sam NewsOctober 29, 2020Today, the Justice Department announced that it will permit state, local, territorial, and tribal task force officers to use body-worn cameras on federal task forces around the nation. The department’s policy will permit federally deputized officers to activate a body-worn camera while serving arrest warrants, or during other planned arrest operations, and during the execution of search warrants. The policy is the result of a pilot program launched by the department last October.[Read More…]
- Secretary Pompeo’s Video Remarks at the Prague 5G Security Conference 2020By Sam NewsSeptember 26, 2020
- Preclearance Request for ApplicationBy Sam NewsSeptember 30, 2020Airport operators and [Read More…]
- Coronavirus (COVID-19): Response and RecoveryBy Sam NewsIn U.S CourtsJuly 2, 2020Federal courts are coordinating with state and local health officials and the Centers for Disease Control and Prevention (CDC) to obtain information about the coronavirus (COVID-19) to aid their response, recovery, and reopening efforts. Courts are regularly releasing orders to address operating status, public and employee safety, and other court business.[Read More…]
- Secretary Michael R. Pompeo at a Press AvailabilityBy Sam NewsOctober 14, 2020
- Man Sentenced for Role in Investment-Fraud SchemeBy Sam NewsMarch 5, 2021A Virginia man was sentenced today to over eight years in prison for his role in an investment-fraud scheme in which he and his co-conspirators stole at least $5.7 million from victim investors.[Read More…]
- 15 Named In $26 Million International Trade Fraud SchemeBy Sam NewsDecember 15, 2020A federal grand jury in Houston, Texas, has returned a criminal indictment against eight individuals, while a related civil complaint has charged 14 individuals and one company relating to international trade fraud violations stemming from a decade-long scheme involving tires from China.[Read More…]
- The Justice Department Unveils Proposed Section 230 LegislationBy Sam NewsSeptember 23, 2020Today, on behalf of the [Read More…]
- Global Coalition to Defeat ISIS Meeting on ISIS Threats in West AfricaBy Sam NewsNovember 9, 2020
- Championing America’s First FreedomBy Sam NewsJanuary 16, 2021
- Attorney General Barr Delivers Opening Remarks at Press Conference Announcing Updates to Operation LegendBy Sam NewsAugust 19, 2020Remarks as Prepared for [Read More…]
- Former Investment Manager Charged in Scheme to Defraud Life Insurance CompanyBy Sam NewsDecember 3, 2020A former investment manager was charged in an indictment unsealed today for his alleged participation in a scheme to defraud a North Carolina-based life insurance company out of over $34 million.[Read More…]
- On Progress Toward PeaceBy Sam NewsDecember 11, 2020
- American Darknet Vendor and Costa Rican Pharmacist Charged with Narcotics and Money Laundering ViolationsBy Sam NewsAugust 4, 2020A dual U.S.-Costa Rican citizen and a Costa Rican citizen, both of whom reside in Costa Rica, were indicted by a federal grand jury in the District of Columbia for their illegal sales of opioids on the darknet.[Read More…]
- Secretary Michael R. Pompeo’s Call with Indian External Affairs Minister S. JaishankarBy Sam NewsSeptember 26, 2020
- Slovenia Travel AdvisoryBy Sam NewsSeptember 26, 2020Reconsider travel to [Read More…]
- U.S. Taxpayer in Panama Papers Investigation Sentenced to PrisonBy Sam NewsSeptember 21, 2020A former U.S. resident and taxpayer was sentenced in the Southern District of New York to four years in prison for wire fraud, tax fraud, money laundering, false statements, and other charges.[Read More…]
- Greece Travel AdvisoryBy Sam NewsSeptember 26, 2020Reconsider travel to [Read More…]
- Department of Justice Invests More than $87 Million in Grants to Address School ViolenceBy Sam NewsOctober 9, 2020The Department of [Read More…]
- Owner of Japanese Fishing Vessel Pleads Guilty to Unlawful Trafficking of Shark FinsBy Sam NewsOctober 9, 2020Hamada Suisan Co. Ltd., the owner of the Japanese-flagged fishing vessel, M.V. Kyoshin Maru No. 20, pleaded guilty, pursuant to a plea agreement, to aiding and abetting the attempted export of shark fins out of Hawaii in violation of the Lacey Act, the Department of Justice announced.[Read More…]
- Secretary Michael R. Pompeo With Ben Shapiro of The Ben Shapiro ShowBy Sam NewsDecember 15, 2020
- Secretary Blinken’s Call with Ethiopian Prime Minister Abiy AhmedBy Sam NewsApril 26, 2021
- Agricultural Developer Agrees to Pay Clean Water Act Fines, Mitigate Impacts to Sensitive Streams and WetlandsBy Sam NewsJanuary 19, 2021A California agricultural developer has agreed to pay a civil penalty, preserve streams and wetlands, effect mitigation, and be subject to a prohibitory injunction to resolve alleged violations of the Clean Water Act (CWA) on property near the Sacramento River located in Tehama County, California, the Justice Department announced today.[Read More…]
- Assassination of Lebanese Activist Lokman SlimBy Sam NewsFebruary 4, 2021
- The United States Condemns the Kidnapping of Students in Kankara, NigeriaBy Sam NewsDecember 17, 2020Cale Brown, Principal [Read More…]
- Join NASA for the Launch of the Mars 2020 Perseverance RoverBy Sam NewsIn SpaceSeptember 26, 2020No matter where you [Read More…]
- Secretary Blinken’s Meeting with Japanese Foreign Minister Motegi and Republic of Korea Foreign Minister ChungBy Sam NewsMay 5, 2021
- South Sudan Travel AdvisoryBy Sam NewsSeptember 26, 2020Do not travel to South [Read More…]
- Joint Statement Regarding the Vision for Advancing the U.S.-Bangladesh Economic PartnershipBy Sam NewsOctober 5, 2020
- Secretary Antony J. Blinken to State Department EmployeesBy Sam NewsJanuary 27, 2021
- Owner of New York Tax Preparation Business Pleads Guilty to Conspiring to File False ReturnsBy Sam NewsJuly 30, 2020A Queens, New York return preparer pleaded guilty today to conspiracy to defraud the United States by filing false returns, announced Principal Deputy Assistant Attorney General Richard E. Zuckerman of the Justice Department’s Tax Division.[Read More…]
- On the First Anniversary of the Death of Abu Bakr al-Baghdadi By Sam NewsOctober 27, 2020
- North Carolina Nail Salon Owner Convicted of Forced LaborBy Sam NewsJanuary 8, 2021The Justice Department announced today that after a five-day trial, a federal jury in Charlotte, North Carolina, found Thuy Tien Luong, 37, of Charlotte, North Carolina, guilty of forced labor after finding that Luong compelled the labor of one of her nail technicians at a nail salon she owned and operated in Davidson, North Carolina.[Read More…]
- Operation Legend: Case of the DayBy Sam NewsOctober 6, 2020A Detroit man was charged in federal court with drug trafficking and illegally possessing a firearm.[Read More…]
- Kansas Man Indicted on Federal Child Pornography ChargesBy Sam NewsSeptember 16, 2020A resident of Topeka, Kansas, has been indicted by a federal grand jury in the U.S. District Court for the District of Kansas on federal child pornography charges, Acting Assistant Attorney General Brian Rabbitt of the Justice Department’s Criminal Division announced today.[Read More…]
- Deputy Secretary Biegun’s Call with Japanese Vice Foreign Minister AkibaBy Sam NewsDecember 3, 2020
- Civilian-Military Interaction in Conflicts: Best Practices and Perceptions (Brown University)By Sam NewsSeptember 27, 2020Bureau of Population, [Read More…]
- Visa and Plaid Abandon Merger After Antitrust Division’s Suit to BlockBy Sam NewsJanuary 12, 2021The Department of Justice announced today that Visa Inc. and Plaid Inc. have abandoned their planned $5.3 billion merger.[Read More…]
- Fixed-Price-Incentive Contracts: DOD Has Increased Their Use but Should Assess Contributions to OutcomesBy Sam NewsFebruary 3, 2021The Department of Defense (DOD) has encouraged the use of fixed-price-incentive (FPI) contracts where appropriate. These contracts can provide defense contractors with a profit incentive for effective cost control and performance depending on how they are structured. Over the 10-year period from fiscal years 2010 through 2019, obligations on FPI contracts for major defense acquisition programs (MDAPs) grew to account for almost half of the $65 billion in obligations for fiscal year 2019. Percentage of Obligations by Contract Type for Major Defense Acquisition Programs from Fiscal Years 2010 through 2019 DOD guidance, including Better Buying Power initiatives, influenced DOD's use of FPI contracts over the last decade for the selected contracts GAO reviewed. In addition, when selecting a contract type, contracting officers also considered factors including the availability of cost or pricing data, previous experience with the contractor, and the previously used contract type. DOD has not assessed the extent to which use of FPI contracts has contributed to achieving desired cost and schedule performance outcomes. DOD spends billions of dollars annually using fixed-price type contracts to acquire its MDAPs, among other things. In 2010, DOD's Better Buying Power guidance encouraged the use of FPI contracts as a way to obtain greater efficiency and productivity in defense spending. Congress included a provision in statute for GAO to report on DOD's use of fixed-price type contracts, including FPI. This report examines (1) the extent to which DOD has awarded FPI contracts associated with MDAPs from fiscal years 2010 through 2019, and (2) the factors that influenced DOD's decision to use FPI contracts and the extent to which DOD assesses their use, among other objectives. GAO analyzed government contracting data by contract type for fiscal years 2010 through 2019 on contracts for 101 MDAPs. GAO further analyzed a non-generalizable sample of 12 contracts including six FPI and six firm-fixed-price (two of each type from each of the three military departments); conducted file reviews; reviewed policy documentation; and interviewed DOD officials. GAO recommends that DOD conduct an assessment of its use of FPI contracts for major defense acquisition programs, including the extent to which share lines and other contract elements contributed to achieving desired cost and schedule performance outcomes. DOD agreed with GAO's recommendation. For more information, contact W. William Russell at (202) 512-4841 or email@example.com.[Read More…]
- Federal Research Grants: OMB Should Take Steps to Establish the Research Policy BoardBy Sam NewsFebruary 3, 2021As of January 2021, the Office of Management and Budget (OMB) had not established the Research Policy Board as required by the 21st Century Cures Act. The act requires OMB to establish the Board within 1 year of the December 13, 2016 enactment of the act. The Board is to provide information on the effects of regulations related to federal research requirements. OMB stated that it had not established the Board because of issues with the Department of Health and Human Services’ (HHS) and other federal agencies’ full participation in the Board’s potential activities to develop or implement a modified approach to indirect cost policies. According to OMB, “the Board would necessarily delve into issues related to compliance burden and indirect cost reimbursement to entities that receive federal funding for research.” Specifically, OMB pointed to a statutory provision appearing in annual appropriations bills that it believes prohibits HHS and other agencies from taking action on issues that could implicate certain indirect cost provisions. According to OMB, this provision could, if continued in future bills, “complicate or even possibly prohibit HHS from participating in major elements of the Board’s process.” OMB stated that, without representation of a major research agency such as the National Institutes of Health (NIH), which is part of HHS, “OMB would not be equipped to meet the statutory goals of the Board.” However, HHS stated in October 2020 that the indirect cost provision would not prohibit NIH’s participation on the Board and that the department was not aware of any other appropriations law provision that would prohibit such participation. GAO has no basis to disagree with HHS’s position. The 21st Century Cures Act does not specifically direct the Board to examine issues related to indirect costs, and we identified other issues that may fall within the scope of the Board’s activities. For example, the act specifies five activities that the Board may conduct, including creating a forum for the discussion of research policy or regulatory gaps, and identifying regulatory process improvements and policy changes. The Board could consider examining these or other issues related to streamlining and harmonizing regulations and reducing administrative burden in federally funded research in accordance with the 21st Century Cures Act. By not having established the Board, OMB is missing opportunities for the Board to provide information on the effects of regulations related to requirements for federally funded research, and to make recommendations to harmonize and streamline such requirements. Further, OMB has limited time to establish the Board and the Board may have insufficient time to complete its work before the Board is set to terminate on September 30, 2021. The 21st Century Cures Act requires OMB to establish an advisory committee, to be known as the Research Policy Board, that is responsible for making recommendations on modifying and harmonizing regulation of federally funded research to reduce administrative burden. The Board is to consist of both federal and non-federal members and include not more than 10 members from federal agencies, including officials from OMB, the Office of Science and Technology Policy (OSTP), HHS, the National Science Foundation, and other departments and agencies that support or regulate scientific research, as determined by the OMB Director. The 21st Century Cures Act includes a provision for GAO to conduct an independent evaluation of the Board’s activities. This report examines the steps OMB has taken to establish the Board as required by the 21st Century Cures Act. GAO reviewed written responses and other information from OMB, HHS, and OSTP; the 21st Century Cures Act and other laws related to the Board and its establishment; relevant reports on issues related to administrative burden; and related documents such as memoranda and agency guidance. GAO submitted a draft report containing the results of its evaluation to Congress on December 10, 2020. Congress should consider extending the period of authorization for the Research Policy Board, giving OMB additional time to establish the Research Policy Board and complete its statutory mission under the 21st Century Cures Act. GAO recommends that OMB establish the Research Policy Board as mandated by the 21st Century Cures Act and report to Congress on the Board’s activities. OMB did not agree or disagree with this recommendation. We maintain that the evidence in this report shows the need for our recommendation. For more information, contact John Neumann at (202) 512-6888 or firstname.lastname@example.org.[Read More…]
- Riverside, California Man Who Admitted Planning Mass Casualty Attacks and Purchasing Firearms Later Used in 2015 Terrorist Attack in San Bernardino Ordered to Serve 20-Year Federal Prison SentenceBy Sam NewsOctober 23, 2020A Riverside man was sentenced today to 20 years in federal prison for conspiring to commit terrorist attacks in the Inland Empire and for providing assault rifles later used in the 2015 San Bernardino terrorist attack that killed 14 people.[Read More…]
- Acting Deputy Attorney General John Carlin Delivers Remarks on Domestic TerrorismBy Sam NewsFebruary 26, 2021Thank you, Marc. Before I begin, I’d like to address an important issue: the reports of horrific attacks on Asian Americans across the country. I want to be clear here: No one in America should fear violence because of who they are of what they believe. Period. These types of attacks have no place in our society. We will not tolerate any form of domestic terrorism or hate-based violent extremism, and we are committed to putting a stop to it.[Read More…]
- Justice Department Settles Claims Against City of Meriden, Connecticut, Involving Denial of MosqueBy Sam NewsNovember 5, 2020The Justice Department and the U.S. Attorney’s Office for the District of Connecticut today announced an agreement with the City of Meriden, Connecticut to resolve allegations that the city violated the Religious Land Use and Institutionalized Persons Act of 2000 (RLUIPA) by denying the application of the Omar Islamic Center to establish a mosque in March 2019, and by maintaining a zoning code that treats religious assemblies and institutions on less than equal terms with nonreligious assemblies and institutions in nine zoning districts.[Read More…]
- North Carolina Return Preparer Indicted for Tax Fraud SchemeBy Sam NewsNovember 18, 2020A federal grand jury sitting in Greenville, North Carolina, returned an indictment charging a North Carolina tax preparer with conspiracy to defraud the United States and with preparing false returns for clients, announced Principal Deputy Assistant Attorney General Richard E. Zuckerman of the Justice Department’s Tax Division and U.S. Attorney Robert J. Higdon, Jr. for the Eastern District of North Carolina.[Read More…]
- Georgia Man Sentenced to Prison for Running Ponzi SchemeBy Sam NewsSeptember 25, 2020A Georgia man has been sentenced to 60 months in prison followed by three years of supervised release for running a Ponzi scheme that ensnared over a hundred victims, and induced college students and others to part with money for his own personal benefit.[Read More…]
- Alabama Doctor Sentenced for Conspiracy to Distribute a Controlled SubstanceBy Sam NewsMay 5, 2021An Alabama doctor and her husband were sentenced Tuesday to 52 and 30 months in prison respectively for prescribing and dispensing controlled substances without a legitimate medical purpose and outside the course of professional practice.[Read More…]
- National Day of the Federated States of MicronesiaBy Sam NewsNovember 2, 2020
- Trinidad and Tobago Travel AdvisoryBy Sam NewsSeptember 26, 2020Reconsider travel [Read More…]
- House of Representatives Vote on a Libyan Interim Government of National UnityBy Sam NewsMarch 10, 2021
- Six Additional Individuals Indicted On Antitrust Charges In Ongoing Broiler Chicken InvestigationBy Sam NewsOctober 7, 2020A federal grand jury in the U.S. District Court in Denver, Colorado, returned a superseding indictment charging six additional defendants for their roles in a previously indicted conspiracy to fix prices and rig bids for broiler chicken products, and containing additional allegations against the previously charged defendants in the same conspiracy, the Department of Justice announced today. The superseding indictment also charges one defendant with making false statements and obstruction of justice.[Read More…]